Individual provider · Type 1 NPI
Kaitlin Tindel, PharmD
Clinical Pharmacology Physician · Dallas, TX
NPI number
1033056858
Active
Practice location
1935 Medical District Dr
Dallas, TX 75235-7701
Mailing address
718 Preston Pl
Grapevine, TX 76051-5700
Specialties and licenses
| Taxonomy | Code | License |
|---|---|---|
| Clinical Pharmacology Physician Primary | 208U00000X | 61204 (TX) |
Clinical Pharmacology Physician: Clinical pharmacology encompasses the spectrum of activities related to the discovery, development, regulation, and utilization of safe and effective drugs.
1,160 other providers at this address
- Anesthesiologists for ChildrenPain Medicine (Anesthesiology) Physician Dallas, TX NPI 1700837408
- Children's Health System of TexasCommunity/Retail Pharmacy Dallas, TX NPI 1124998562
- Children's Health System of TexasChildren's Hospital Dallas, TX NPI 1194743013
- Children's Health System of TexasEnd-Stage Renal Disease (ESRD) Treatment Clinic/Center Dallas, TX NPI 1922428234
- Children's Medical Center DallasChildren's Hospital Dallas, TX NPI 1700183860
- Complex Care Medical Services CorporationPediatrics Physician Dallas, TX NPI 1013256098
- Dallas Cystic Fibrosis Center, PAPediatric Pulmonology Physician Dallas, TX NPI 1457475162
- Dallas Physician Medical Services for Children IncPediatrics Physician Dallas, TX NPI 1194153650
- Dallas Physician Medical Services for Children IncUrgent Care Clinic/Center Dallas, TX NPI 1417863077
- Dallas Physician Medical Services for Children IncPediatrics Physician Dallas, TX NPI 1558407908
- Neurosurgeons for Children, P.a.Specialist Dallas, TX NPI 1972629400
- Pediatric Anesthesia AssociatesAnesthesiology Physician Dallas, TX NPI 1477979367
Other clinical pharmacology physician providers in Dallas
About NPI 1033056858
Kaitlin Tindel, PharmD's National Provider Identifier is 1033056858, issued on Apr 30, 2026. The primary taxonomy on file is Clinical Pharmacology Physician (208U00000X), and the practice location is in Dallas, TX. The record was last updated on Apr 30, 2026.